Kyntra Bio Inc's Customers Performance

Name: Kyntra Bio Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

KYNB

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


KYNB's Source of Revenues		During the corresponding time, Kyntra Bio Inc recorded a revenue increase by 36.47 % year on year, sequentially revenue grew by 192.72 %. While revenue at the Kyntra Bio Inc 's corporate clients • List of KYNB Customers

for the same period Kyntra Bio Inc recorded revenue increase by 36.47 % year on year, sequentially revenue grew by 192.72 %.

• List of KYNB Customers

Kyntra Bio Inc's Business Units


Drug Product Revenue Net	93.42 %	of total Revenue
Drug Product Revenue Net Astellas Agreement	93.63 %	of total Revenue
Drug Product Revenue Net Astellas Agreement Japan	-58.61 %	of total Revenue
Drug Product Revenue Net Astellas Agreement Europe	152.03 %	of total Revenue
Europe Astellas Europe Agreement	88.28 %	of total Revenue
Drug Product Revenue Net Europe Astellas Agreement	152.03 %	of total Revenue
Drug Product Revenue Net Japan Astellas Agreement	-58.61 %	of total Revenue
Drug Product Revenue Net API Shipment	58.86 %	of total Revenue
Bulk Drug Product Astellas Europe Agreement	165.86 %	of total Revenue
Bulk Drug Product Europe Astellas Europe Agreement	13.38 %	of total Revenue
Bulk Drug Product Europe Astellas Europe Agreement Royalty Revenue	40.13 %	of total Revenue

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Kyntra Bio Inc's Comment on Sales, Marketing and Customers

The company provides services to customers, physicians, and third-party payors, including commercial insurers, within the healthcare market. Its relationships and operations are governed by various healthcare fraud and abuse laws, false claims laws, transparency laws, and other regulations in the United States and internationally. These laws affect the company's research, sales, marketing, and distribution activities, particularly if its product candidates obtain U.S. marketing approval. Compliance with these regulations is essential to prevent significant penalties and operational limitations.

Kyntra Bio Inc’s Comment on Sales, Marketing and Customers

KYNB's Stock Performance relative to it's Customers

KYNB's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Kyntra Bio Inc	31.61	0.00	0.00	-
SUBTOTAL	0.00	0.00	0.00	-

Sources: Kyntra Bio Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Kyntra Bio Inc’s corporate clients.
For your research, we’ve provided 9 tables on Kyntra Bio Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.